9:22 AM
Leo Group India
| ||
| ||
| Chugai Pharmaceutical opens S$1.5m research institute in S'pore Channel News Asia Japanese bio-tech firm Chugai Pharmaceutical will spend some S$200 million on antibody research in Singapore over the next five years. See all stories on this topic » | ||
| Par Formulations (Formerly Edict Pharmaceuticals) Receives First ANDA Approval MarketWatch (press release) WOODCLIFF LAKE, N.J., July 13, 2012 /PRNewswire via COMTEX/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) today announced that its operating subsidiary, Par Formulations Private Limited, (formerly Edict Pharmaceuticals Private Limited), ... See all stories on this topic » | ||
| WATSON PHARMACEUTICALS, INC. : Watson's Generic Version of Plan B One ... 4-traders PARSIPPANY, N.J., July 13, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. today announced that its subsidiary Watson Laboratories, Inc., has received approval from the United States Food... | July 13, 2012. See all stories on this topic » | ||
| Watson's Generic Version of Plan B One-Step® Receives FDA Approval MarketWatch (press release) PARSIPPANY, N.J., July 13, 2012 /PRNewswire via COMTEX/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI) today announced that its subsidiary Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration (FDA) for ... See all stories on this topic » | ||
| PAR PHARMACEUTICAL COMPANIES, INC. : Par Formulations (Formerly Edict ... 4-traders WOODCLIFF LAKE, N.J., July 13, 2012 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that its operating subsidiary, Par Formulations Private Limited, , received its first... | July 13, 2012. See all stories on this topic » | ||
| Watson Pharmaceuticals Inc. will market generic morning after pill NorthJersey.com Watson Pharmaceuticals Inc. said Friday that it is preparing to sell a generic version of the "morning after" pill. See all stories on this topic » | ||
| Erring pharma firms have a hand in own undoing Times of India A recent study conducted by the appellate authority of Andhra Pradesh Pollution Control Board (APPCB) was what eventually helped it nail the 12 erring pharmaceutical units that were issued closure notices on Thursday. See all stories on this topic » | ||
| Watson Pharmaceuticals: FDA Approves Generic of Teva's Plan B Emergency ... NASDAQ NASDAQ News: Watson Pharmaceuticals: FDA Approves Generic of Teva's Plan B Emergency Contraceptive. See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment